NCT03380351Completed
Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)
The Implementation of Cognitive Screening and Educational Support to Improve Outcomes of Adolescents and Young Adults With Sickle Cell Disease: From Clinic to the Community and Back
Source: ClinicalTrials.gov · Last updated 8 May 2024
Brief summary (registry, in English)
The goal of this study is to specify the interventions, implementation strategies and control conditions from the Sickle Cell Disease Implementation Consortium (SCDIC) using a mixed-methods approach to study site materials and conduct semi-structured qualitative interviews with site representatives (N=3 per site). We focused on the Emergency Department Working Group from the SCDIC working groups.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 17 (actual)
- First submitted
- 20 Nov 2017
- Start date
- 26 Aug 2019
- Primary completion date
- 1 Mar 2024
- Lead sponsor
- Washington University School of Medicine
- Diseases
- Sickle cell disease
- NCT number
- NCT03380351
What you commit to
- Study type: Observational
- Participants enrolled: 17
- From 26 Aug 2019 to the primary completion date, 1 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- none
Who the study is looking for
- three representatives of each of the SDIC sites: the Principal Investigator, and two people nominated by the PI.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Washington University in St. Louis Coordinator of this site? Confirm its status | St Louis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.